stromal vascular fraction
Trials 17
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 15 trials | ||||||
| Phase 1 | NCT04771442 | Sep 2022 → Dec 2023 | Peyronie disease | Esbjerg Hospital - University Hospital of Southern Denmark | Completed | No outcome recorded |
| Phase 1 | NCT05232903 | Mar 2022 → Jun 2024 | intracerebral hemorrhage | Beijing Tiantan Hospital | Unknown | No outcome recorded |
| Phase 1 | NCT05354544 | Aug 2021 → Dec 2024 | — | Shane A. Shapiro | Terminated | No outcome recorded Stop: Business |
| Phase 1 | NCT03940950 | Jul 2019 → May 2025 | osteoarthritis, knee | Mayo Clinic | Completed | No outcome recorded |
| Phase 1 | NCT03882983 | Sep 2017 → Dec 2022 | chronic ulcer of skin | Antria | Unknown | No outcome recorded |
| Phase 1/24 trials | ||||||
| Phase 1/2 | NCT03061110 | Nov 2018 → Dec 2020 | radiation-induced disorder | Midwestern Regional Medical Center | Withdrawn | No outcome recorded Stop: Business |
| Phase 1/2 | NCT03189628 | Mar → Aug 2017 | — | Shanghai Jiao Tong University School of Medicine | Unknown | No outcome recorded |
| Phase 1/2 | NCT02520843 | Oct 2015 → Feb 2018 | Crohn disease | Assistance Publique Hopitaux De Marseille | Completed | No outcome recorded |
| Phase 1/2 | NCT02546882 | Feb 2015 → Jun 2016 | — | Shanghai Jiao Tong University School of Medicine | Unknown | No outcome recorded |
| Phase 23 trials | ||||||
| Phase 2 | NCT04050111 | Aug 2019 → Feb 2021 | osteoarthritis, knee | Swiss Medica XXI Century S.A. | Unknown | No outcome recorded |
| Phase 2 | NCT02866552 | Jan 2017 → Jan 2019 | systemic sclerosis | Assistance Publique Hopitaux De Marseille | Unknown | No outcome recorded |
| Phase 2 | NCT02526576 | Aug 2015 → Jul 2017 | facial hemiatrophy | Antria | Completed | No outcome recorded |
| Phase 41 trial | ||||||
| Phase 4 | NCT07405840 | Jun 2025 → Aug 2026 overdue | osteoarthritis | Clinical Center of Vojvodina | Active not recruiting | No outcome recorded |
| Phase not applicable4 trials | ||||||
| — | NCT07114692 | Sep 2025 → Sep 2027 expected | — | Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University | Not yet recruiting | No outcome recorded |
| — | NCT07094958 | Jul → Dec 2025 overdue | acne | Seoul National University Hospital | Not yet recruiting | No outcome recorded |
| — | NCT06524011 | Dec 2024 → Dec 2025 overdue | — | Zagazig University | Not yet recruiting | No outcome recorded |
| — | NCT02975960 | Oct 2016 → Oct 2017 | systemic sclerosis | The Catholic University of Korea | Completed | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT02558543 Comparator | Sep 2015 → Dec 2018 | systemic sclerosis | Assistance Publique Hopitaux De Marseille | Terminated | No outcome recorded |
Evidence & citations 9 cited values
Every value below carries the sentence it was read from. 20 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Stromal Vascular Fraction | “Stromal vascular fraction (SVF) is a structural framework in the body's fat tissue, comprising mesenchymal stem cells, white blood cells, red blood cells, endothelial cells, T...” NCT05232903 ↗17“The purpose of this research study is to assess if autologous Stromal Vascular Fraction (SVF) taken from the stomach or hips can help heal vocal fold scars.” NCT05354544 ↗ “Biological/Vaccine: Stromal Vascular Fraction The SVF obtained from adipose tissue will be added to the graft” NCT03882983 ↗ “The stromal vascular fraction obtained from adipose tissue will be added to the graft” NCT02526576 ↗ |
| Known as | adipose tissue-derived stromal vascular fraction | “adipose tissue-derived stromal vascular fraction for treating hands of patients with systemic sclerosis” PMID 34297066 ↗ May 2022 |
| Known as | adipose-derived stromal vascular fraction | “Autologous adipose-derived stromal vascular fraction (ADSVF) is an easily accessible source of cells with angiogenic, anti-inflammatory, immunomodulatory, and regenerative properties.” PMID 29321063 ↗ Jan 2018 |
| Known as | ADSVF | “Autologous adipose-derived stromal vascular fraction (ADSVF) is an easily accessible source of cells with angiogenic, anti-inflammatory, immunomodulatory, and regenerative properties.” PMID 29321063 ↗ Jan 2018 |
| Known as | Stromal Vasular Fraction | “Biological: Stromal Vasular Fraction” NCT02526576 ↗ |
| Known as | SVF | “Stromal vascular fraction (SVF) is a structural framework in the body's fat tissue, comprising mesenchymal stem cells, white blood cells, red blood cells, endothelial cells, T...” NCT05232903 ↗7“Autologous stromal vascular fraction (SVF) isolated from adipose tissue was injected intradermally into one side of the face to evaluate its efficacy in treating atrophic acne scars.” NCT07094958 ↗ “The purpose of this research study is to assess if autologous Stromal Vascular Fraction (SVF) taken from the stomach or hips can help heal vocal fold scars.” NCT05354544 ↗ “stromal vascular fraction (SVF) is administered to the patient suffering of Refractory Crohn's disease around of the fistula by local mico injection” NCT02520843 ↗ “Stromal vascular fraction (SVF) enriched platelet rich plasma (PRP) versus each alone” NCT06524011 ↗ “Autologous Adipose-Derived SVF (Stromal Vascular Fraction)” NCT03940950 ↗ “The harvested pellet is stromal vascular fraction (SVF)” NCT03189628 ↗ “to acquire the stromal vascular fraction (SVF).” NCT07114692 ↗ |
| Action | Restore | “promote cartilage repair” NCT07405840 ↗ |
| Modality | Cell therapy | “Adipose tissue, originally used to increase volume, is also characterized by trophic properties associated to stromal vascular fraction (SVF), which contain multipotent stem...” NCT02866552 ↗ |
| Route | Other | “the local injection of 14 ml of microfat and approximately 20 million viable ADSVF cells into the soft tissue around the fistulas” PMID 29321063 ↗ Jan 2018 |